V.5

CUMMING SCHOOL OF MEDICINE Office of Continuing Medical Education and Professional Development

REGISTER ONLINE cumming.ucalgary.ca/cme

PAPERLESS COURSE Access to learning materials will be made available on the course website

Check the website for any program updates cumming.ucalgary.ca/cme/courses

COURSE OVERVIEW

The focus of the Alberta Opioid Dependency Treatment Virtual Training Course is to provide healthcare providers with the knowledge, skills and attitudes required to work with patients who have opioid use disorder (OUD).

COURSE OBJECTIVES

At the end of this course, learners will be equipped to:

• describe the current impact of the opioid crisis within Alberta, and Canada

• explain various opioids and their pharmacological principles

• describe opioid use disorder and how to properly assess for this condition

• recognize biopsychosocial treatment strategies for opioid use disorder

• describe harm reduction philosophies and strategies for opioid use disorder

• define opioid agonist treatment (OAT) therapy and how it aligns with the spectrum oftreatment intensity (1st line vs 2nd line treatment recommendations)

• explain how to initiate, stabilize and convert (partial to full agonist) individuals on OAT therapy

• describe how to taper and stabilize and withdraw individuals off long term opioid agonisttreatment therapy

• differentiate special population treatment considerations and opioid use disorder

• identify experts, mentors and consultation services across the province which can provideexpertise and support for competency development within opioid agonist treatment therapy

WHO SHOULD REGISTER

Physicians, Pharmacists, Nurse Practitioners, Pharmacy Technicians, Other Healthcare Professionals and First Responders working with patients with opioid use disorder (OUD)

ALBERTA OPIOID DEPENDENCY TREATMENT VIRTUAL TRAINING COURSE (FREE)Self-Paced Online Modules

cumming.ucalgary.ca/cme

ALBERTA OPIOID DEPENDENCY TREATMENT VIRTUAL TRAINING COURSE | PAGE 1 OF 7

CREDITS

Mainpro+ Self-Learning – up to 10.0 credits MOC Section 3 Self-Assessment – up to 10.0 hours

V.5

The self-learning activity consists of seven online self-paced modules:

1 The Opioid Crisis

2 Understanding Opioids

3 Impact of Opioid Use

4 Reducing Harm and Recognizing Opioid Poisoning

5 Treatment Planning: Opioid Agonist Treatment (OAT) Therapy

6 Treatment Planning: Psychosocial Interventions

7 Special Populations

To obtain your prescription privileges upon completion of the online modules you will be required to send your certificate of completion to the CPSA.

The CPSA no longer requires for physicians to do a post-training preceptorship in order to prescribe methadone. Completion of the Alberta Opioid Dependency Treatment Virtual Training Course or its equivalent is all that is required.

PROGRAM DETAILS

PROGRAM MAY CHANGE DUE TO CIRCUMSTANCES BEYOND OUR CONTROL

cumming.ucalgary.ca/cme

REGISTRATION INSTRUCTION

SELF-REGISTRATION

Create an ECME e-Learning Profile or login to an existing profile at http://ecme.ucalgary.ca. Once logged in, go to 'e-Learning Courses' from the main menu. Find this course in the course listing, select the most appropriate version for your profession: Initiating OAT Prescriber + Other Health Professionals, Maintaining OAT Prescriber or First Responders. After submitting your registration, right away you will be redirected to start the course.

WORKING AT YOUR OWN PACE

You may leave and return to the course at any time. When you login again (http://ecme.ucalgary.ca), click on 'RESUME LEARNING' in the page. It will bring you back to where you left off.

ALBERTA OPIOID DEPENDENCY TREATMENT VIRTUAL TRAINING COURSE | PAGE 2 OF 7

V.5

ONLINE MODULES

1 The Opioid Crisis• describe the national and provincial impact of the current

opioid crisis• describe current action, legislation and prescribing guidelines

that have been established in response to the opioid crisis• explain how Canada’s current opioid crisis came to be• explain the impact of the opioid crisis on individuals, and families

2 Understanding Opioids• describe how opioids evolved• explain the impact opioids have on the brain and body, and the

routes of administration; describe the various opioids available• explain the endogenous/exogenous system and interaction

with opioid receptors• explain opioid agonist activity and affinity• describe current trends in opioid use

3 Impact of Opioid Use• explain the neurobiology of addiction; describe opioid use disorder• discuss the impacts of opioids on mental and physical health• explore OUD across special populations• discuss the biopsychosocial-spiritual model of addiction• explain the components of a comprehensive assessment for opioid

dependency treatment• conduct a comprehensive assessment for opioid use disorder (OUD)

4 Reducing Harm and Recognizing Opioid Poisoning• define harm reduction and the philosophy and principles behind it• describe four primary components of harm reduction• explain the signs and symptoms of opioid intoxication and poisoning• explain harm reduction approaches as it relates to opioid use

disorder and current initiatives underway in Alberta• assess for an opioid poisoning and respond with administration

of naloxone

5 Treatment Planning: Opioid Agonist Treatment (OAT) Therapy• define opioid agonist treatment (OAT) therapy and how it aligns

with the spectrum of treatment intensity• describe 1st line vs 2nd line treatment recommendations• explain how to initiate, maintain and convert when prescribing

OAT therapies• explain efficacy of medically assisted withdrawal treatment• describe specialty led OAT therapy (SROM & iOAT)• explain clinical requirements and nuances of OAT monitoring• initiate an individual on methadone• initiate an individual on buprenorphine/naloxone through

home induction• convert an individual from methadone to buprenorphine/naloxone

LEARNING OBJECTIVES

PROGRAM MAY CHANGE DUE TO CIRCUMSTANCES BEYOND OUR CONTROL

cumming.ucalgary.ca/cme

ALBERTA OPIOID DEPENDENCY TREATMENT VIRTUAL TRAINING COURSE | PAGE 3 OF 7

6 Treatment Planning: Psychosocial Interventions• describe integrated treatment• discuss how motivation for change and comprehensive

assessment inform psychosocial intervention andtreatment placement

• explain the goals of psychosocial treatment• explain the efficacy of various psychosocial interventions

in relation to opioid use disorder

7 Special Populations• discuss the prevalence of OUD across developmental and

special population cohorts• describe prescribing OAT recommendations and special

considerations for each population cohort• explain clinical interactions and strategies most supportive

to the unique requirements of demographic and specialpopulation cohorts presenting with OUD

V.5

PLANNING COMMITTEE

Jill Mitchell BA Course Co-Chair Director, Alberta Health Services – Professional Development & Concurrent Capability, Provincial Addiction and Mental Health, Alberta Health Services

Michael Trew MD FRCPC Course Co-Chair Medical Lead, Addiction and Mental Health Special Project, Alberta Health Services

Avi Aulakh MD FRCPC(Psych) DABAM Clinical Lecturer, University of Alberta; Alberta Health Services

Brett Baumback BScPharm RPh Pharmacist, Rexall Specialty Pharmacy (Katz Group Ltd)

Nathaniel Day MD CCFP Alberta Health Services; Minister's Opioid Emergency Response Commission

Dawn Edwards BAPsych Program Consultant, Alberta Health Services

Laura Evans MD CCFP CSAM(C) ISAM(C) DABAM Clinical Assistant Professor, University of Calgary; Co-Medical Lead, Addiction Centre, Alberta Health Services; CSAM

Calder Fertig BA Senior Advisor, Professional Development & Concurrent Capability, Provincial Addiction and Mental Health, Alberta Health Services

Monty Ghosh BSc MBT MSc MD FRCPC DM-EMDM ISAM(C) Clinical Assistant Professor, University of Alberta; Alberta Health Services

Nadeem Hirji Program Consultant, Professional Development & Concurrent Capability, Provincial Addiction and Mental Health, Alberta Health Services

Ron Lim MD CCFP DABAM DFASAM FISAM CCSAM MRO Clinical Associate Professor, University of Calgary; Medical Lead, Calgary Opioid Dependency Program, Alberta Health Services; CSAM; CRISM

Emily McPhail BHSc(Hons) Medical Student, MD/MSc, University of Calgary

Karine Meador MD CCFP DABAM Assistant Director, Inner City Health and Wellness Program; Staff Physician, Addiction Recovery and Community Health (ARCH), Royal Alexandra Hospital, Edmonton, AB

Carlee Ruddy BA MSc Provincial Addiction and Mental Health, Alberta Health Services

Robert Tanguay BSc (Hons) MD FRCPC CISAM CCSAM Clinical Lecturer, University of Calgary; Alberta Health Services; Transitional Outpatient Pain Program for Spine; CSAM

Hakique Virani MD FRCPC ABAM Clinical Assistant Professor, University of Alberta; Medical Director, Metro City Medical Clinic, Edmonton, AB

Tuxephoni Winsor RN BN MHS Manager, Professional Development, Provincial Addiction and Mental Health, Alberta Health Services

Diane Simpson PhD MDE CME Representative Education Consultant, Office of Continuing Medical Education and Professional Development, University of Calgary

cumming.ucalgary.ca/cme

ALBERTA OPIOID DEPENDENCY TREATMENT VIRTUAL TRAINING COURSE | PAGE 4 OF 7

V.5

cumming.ucalgary.ca/cme

ALBERTA OPIOID DEPENDENCY TREATMENT VIRTUAL TRAINING COURSE | PAGE 5 OF 7

DISCLOSURE OF POTENTIAL FINANCIAL CONFLICTS OF INTEREST

In keeping with accreditation guidelines, speakers participating in this event have been asked to disclose to the audience any involvement with industry or other organizations that may potentially influence the presentation of the educational material. Disclosure will be done verbally and using a slide prior to the speaker’s presentation.

FACULTY

Avi Aulakh MD FRCPC(Psych) DABAM Clinical Lecturer, University of Alberta; Alberta Health Services

Brett Baumback BScPharm RPh Pharmacist, Rexall Specialty Pharmacy (Katz Group Ltd)

Keith Courtney MD FRCPC Medical Director, Corrections Services, Alberta Health Services

Lynne Cousineau Simulation Confederate, Alberta Health Services

Laura Evans MD CCFP CSAM(C) ISAM(C) DABAM Clinical Assistant Professor, University of Calgary; Co-Medical Lead, Addiction Centre, Alberta Health Services; CSAM

Monty Ghosh BSc MBT MSc MD FRCPC DM-EMDM ISAM(C) Clinical Assistant Professor, University of Alberta; Alberta Health Services

Jessica Holtsbaum Changing the Face of Addiction

Ron Lim MD CCFP DABAM DFASAM FISAM CCSAM MRO Clinical Associate Professor, University of Calgary; Medical Lead, Calgary Opioid Dependency Program, Alberta Health Services; CSAM; CRISM

Ryan Luhning Simulation Confederate, Alberta Health Services

Joseph McMannus Simulation Confederate, Alberta Health Services

Karine Meador MD CCFP DABAM Assistant Director, Inner City Health and Wellness Program; Staff Physician, Addiction Recovery and Community Health (ARCH), Royal Alexandra Hospital, Edmonton, AB

Celine Meggison-Smith Simulation Confederate, Alberta Health Services

John Pereira MD CCFP Physician, Chronic Pain Centre, Alberta Health Services

Emily Schoen Simulation Confederate, Alberta Health Services

Esther Tailfeathers MD CCFP Senior Medical Director, Indigenous Health Strategic Clinical Network, Alberta Health Services

Robert Tanguay BSc (Hons) MD FRCPC CISAM CCSAM Clinical Lecturer, University of Calgary; Alberta Health Services; Transitional Outpatient Pain Program for Spine; CSAM

Kenedee Taylor Changing the Face of Addiction

Shandra Taylor Changing the Face of Addiction

Hakique Virani MD FRCPC ABAM Clinical Assistant Professor, University of Alberta; Medical Director, Metro City Medical Clinic, Edmonton, AB

V.5

cumming.ucalgary.ca/cme

ALBERTA OPIOID DEPENDENCY TREATMENT VIRTUAL TRAINING COURSE | PAGE 6 OF 7

ACCREDITATION

STUDY CREDITS

The University of Calgary – Office of Continuing Medical Education and Professional Development is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME).

CFPC

MAINPRO+ SELF-LEARNING

This one-credit-per-hour Self-Learning program meets the certification criteria of The College of Family Physicians of Canada and has been certified by the University of Calgary Office of Continuing Medical Education and Professional Development for up to 10.0 Mainpro+ credits.

RCPSC

This course was co-developed with Provincial Addiction and Mental Health, Alberta Health Services and was planned to achieve scientific integrity, objectivity and balance.

MOC SECTION 3 SELF-ASSESSMENT PROGRAM

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by University of Calgary Office of Continuing Medical Education and Professional Development. You may claim a maximum of 10.0 hours (credits are automatically calculated).

V.5

cumming.ucalgary.ca/cme

ALBERTA OPIOID DEPENDENCY TREATMENT VIRTUAL TRAINING COURSE | PAGE 7 OF 7

ADDITIONAL PROGRAM INFORMATION

SPONSORSHIP

FOR FURTHER INFORMATION

Office of Continuing Medical Education and Professional Development, Cumming School of Medicine, University of Calgary, TRW Building, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6

ABOUT COURSE CONTENT

Diane Simpson, Education Consultant Phone 403.210.8804 Email dsimpson@ucalgary.ca

ABOUT REGISTRATION AND ACCESS TO THE COURSE

Email ecme@ucalgary.ca

This program has received an educational grant or in-kind support from Alberta Health.